Faculty

Jennifer Hamilton

MSPAS, PA-C

Baltimore, MD, USA

Melissa Ferrari

PA

San Diego, CA, USA

Bharati Bhardwaja

PharmD

Denver, CO, USA

Alison Moe

PA-C

Atlanta, GA, USA

Elizabeth Goacher

PA-C, MHS

Raleigh, NC

Ann Moore

NP

Phoenix, AZ

Christina Hanson

FNP-C

South Denver Gastroenterology

Gabriella McCarty

NP-C

North Shore Gastroenterology

Tedra Gray

NP-C

Sinai Medical Group

Kimberly Orleck

PA-C

Atlanta Gastroenterology Associates

Podcasts

Podcast: How Do You Best Support Patients Getting Started on New MASH Treatments?

April 2026

Podcast: Best Practices For MASH Patient Identification

April 2026

SubQ Solutions: Induction and Maintenance in Moderately to Severely Active CD and UC

March 2026

Podcast: Inflammation Intersection: A Rheum-Gi Dialogue

March 2026

Podcast: Upadacitinib FDA Label Update: What Clinicians Need to Know

February 2026

The Conversation That Matters: Talking to Patients About Obesity and IMIDs

December 2025

From Insight to Action: Practical Strategies to Improve Outcomes in Patients with Obesity and IMIDs

November 2025

GHAPPcast: Women of Childbearing Age With IBD

November 2025

The Hidden Costs: Obesity’s Role in Suboptimal Outcomes and Healthcare Burden in IMIDs

November 2025

Podcast: Obesity and IMIDs: Unpacking the Epidemic and Its Far-Reaching Impacts

November 2025

GHAPPcast: Mental and Sexual Health Concerns & How To Address Them For Your IBD Patient

November 2025

GHAPPcast: IBS-C Therapies Explained: Helping Patients Understand Their Options

October 2025

GHAPPcast: Smarter Surveillance: The Rise of Algorithms like GALAD and Their Path to Practice

October 2025

GHAPPcast: Decoding Diagnostics: Why Biomarker Development Phases Are Your Clinical Ally

October 2025

GHAPPcast: Explaining IBS-C: Diagnosis and Communication That Builds Confidence

September 2025

Empowering PBC Patients: APPs’ Role in Education and Support

September 2025

GHAPPcast: Payer Tutorial

September 2025

Setting the Standard in Biomarker Validation: EDRN Example & Lessons from Liver Cancer

September 2025

Navigating Difficult Conversations: Discussing Prognosis and Lifelong Care in PBC

August 2025

Collaborating Across Specialties: How APPs Can Work with Hepatologists & Other Providers in PBC Care

August 2025

Webcasts

Webcast: Florida Viral Hepatitis Network: Hepatitis Elimination Series Part 3

June 2026

Webcast: Florida Viral Hepatitis Network: Hepatitis Elimination Series Part 2

June 2026

Clinical Tipping Points In Portal Hypertension Virtual Broadcast

May 2026

Mastering MASH Management: A 4-Pillar Approach to Patient Care in 2026

March 2026

PBC & PSC: Advancing Diagnostics, Novel Therapeutics and Patient Centered Management Symposium

March 2026

Webcast: Florida Viral Hepatitis Network: Hepatitis Elimination Series Part 1

November 2025

Expert Perspectives on Chronic Liver Disease From ACG & AASLD

January 2026

Targeting the Drivers of IBD: GHAPP National 2025

October 2025

Navigating New Horizons: Evolutions of MASH Care

March 2025

Post Conference MASH Highlights from AASLD

February 2025

Post Conference MASH Highlights From ACG

February 2025

Post Conference MASH Highlights From EASL

February 2025

Post Conference MASH Highlights From DDW

February 2025

Defining, Diagnosing, & Treating MASH

November 2024

Lifestyle Modifications for Patients With MASH

November 2025

Treatment of Metabolic Disorders and the Role of APPs in MASH

November 2025

Updates On Approved Treatments for MASH

November 2025

MASH Bootcamp Q&A

November 2025

Identifying & Diagnosing MASH Patients with Non-Invasive Tests

November 2025

2024 IBD Bootcamp

October 2024

FAQ Video Module

FAQ: QUASAR Long Term Extension Interim Analysis

June 2026

FAQ: Recognizing OHE Risk in Patients with Chronic Liver Disease

May 2026

FAQ: Phase 3 GALAXI 2 & 3: Extraintestinal Manifestations In Moderate to Severe Crohn’s Disease

May 2026

FAQ: Treat Through VS Randomized Withdrawal Design: What's The Difference?

March 2026

FAQ: Biomarkers: The Non-Invasive Future of HCC Detection

February 2026

FAQ: Approved Systemic Therapy in Upadacitinib’s Expanded UC and CD Indications

February 2026

FAQ: What Does Clinically Inadvisable Mean in Upadacitinib’s Expanded UC and CD Indications?

February 2026

FAQ: How Do You Balance Systemic and Liver Directed Therapies in Patients With MASH?

January 2026

FAQ: What is the Relevance of Assessing Alcohol Consumption in Patients With MASH?

January 2026

FAQ: What Role Do NITs Play in Risk Stratification & Patient Selection—& Balancing Patient History?

January 2026

FAQ: What Are the Functional and Prognostic Differences Between Fibrosis F3 and F4 Patients? How Are These Patients Managed Differently?

December 2025

FAQ: How Do You Explain Remission To A Patient?

November 2025

APP Insight: How Do You Develop a Treatment Plan for IBS-C? What Are Some Considerations?

November 2025

FAQ: What Is the Importance of Biomarkers Such as Fecal Calprotectin and CRP?

October 2025

FAQ: What Are the Next Steps When a Patient Still Has Active Disease When Taking Advanced Therapy?

October 2025

APP Insight: Conducting Meaningful Conversations to Assess Therapy Impact

October 2025

APP Insight: Evaluating Time to Response and Treatment Effectiveness

September 2025

APP Insight: Why Is It Important to Let Patients Know There Are Different Options for Treatment?

September 2025

What Is the Difference Between CIC and IBS-C?

July 2025

APP Insight: Discussing Exercise as a Complement to IBS-C Treatment

July 2025

Journal Club Videos Module

ASTRO Phase 3 Study: Efficacy and Safety of SC Guselkumab

April 2026

Journal Club: Benefit–Risk Profile of Upadacitinib in Patient’s With Moderate to Severe UC and CD

April 2026

Journal Club: Risankizumab Long-Term Efficacy in Crohn’s Disease: FORTIFY Extension Results

February 2026

Journal Club: Review of Focused Recommendations for the Management of MASLD by APPs in the US

December 2025

Week 48 Efficacy of Guselkumab vs. Ustekinumab in Crohn’s Disease: Insights from GALAXI 2 & 3

March 2025

Efficacy & Safety of Subcutaneous Guselkumab: 48-Week Results from the Phase 3 GRAVITI Study

March 2025

Efficacy and Safety of Guselkumab in Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results

February 2025

Guselkumab Efficacy & Safety in Moderate to Severe CD-GALAXI 2 & 3 Results

February 2025

Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study

January 2025

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis

January 2025

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

September 2024

Medication Review Videos Module

Medication Review: Efficacy & Safety of Risankizumab in Patients with Moderate to Severely Active UC

June 2026

Med Review: SEQUENCE Trial: Risankizumab vs Ustekinumab in Anti-TNF-Refractory Crohn’s Disease

June 2026

Medication Review: Guselkumab IV vs SC Formulation

May 2026

Medication Review: Monotherapy vs. Combination Therapy: Relevance in IBD Treatment Strategy

May 2026

Medication Review: Stable PK Supporting Continuous Inflammatory Control

May 2026

Medication Review: GALAXI & GRAVITI Clinical Trials & LTE Data

March 2026

Medication Review: Resmetirom: Thyroid Hormone Receptor-β Agonism in MASH Treatment

January 2026

Medication Review: Resmetirom: Core Efficacy Data and Patient Selection Considerations

December 2025

What Are Guselkumab's Other FDA Indications and How Might That Affect Patient Care?

February 2025

What Is the Efficacy of Guselkumab in Ulcerative Colitis and Crohn's Disease?

February 2025

What Is the Safety Profile of Guselkumab in Ulcerative Colitis and Crohn's Disease?

February 2025

How Is Guselkumab Dosed in IBD?

January 2025

What Is Non-Responder Imputation and How Is It Utilized in Clinical Trials?

January 2025

Describe the Mechanism of Action of Guselkumab

December 2024

What is Resmetirom and How Does It Work to Treat MASH?

October 2024

What Is the Clinical Profile of Resmetirom, Including Dosing Schedules?

September 2024

Publications

Immunohistochemical analysis and scRNA-Seq identifies vascular endothelial CXCR4 expression as a predictor of poor prognosis in pancreatic ductal adenocarcinoma

July 2026

Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study

July 2026

Editorial: Prediction of Survival in Hepatocellular Cancer-Rise and Fall of the Machines

July 2026

Editorial: Sleeve Gastrectomy vs. Lifestyle Intervention-Redefining the Therapeutic Hierarchy for Adolescent MASLD? Authors' Reply

July 2026

Unexpected Proximal Strictures and Narrowing are Commonly Found During Esophageal Dilation for Eosinophilic Esophagitis

July 2026

Correction to: Computer-Aided Colonoscopy Alert Fatigue and Its Effect on Adenoma Detection

July 2026

Correction to Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)

July 2026

Effects of Pharmacological GIP Infusion on Insulin, Glucagon, and Cardiovascular Responses During Hyperglycemia in Type 2 Diabetes

July 2026

Yttrium-90 radioembolization for neuroendocrine liver metastases: baseline vascularity predicts cytoreduction efficacy

July 2026

Biofilm-derived curli and Z-DNA shape anti-DNA antibody responses during Salmonella infections

July 2026

Associations of demographic, socioeconomic, lifestyle factors and comorbidity with accelerometer-measured physical activity in adults with cardiovascular diseases

July 2026

Breviscapine alleviates liver fibrosis by inhibiting epithelial-mesenchymal transition via TGF-beta1/Smad3 pathway

July 2026

Efficacy and Safety of Balloon Endoscopy-Assisted Peroral Cholangiopancreatoscopy (POCPS) Using a Novel 9Fr Cholangioscope in Patients With Surgically Altered Anatomy: A Dual-Center Retrospective Study (With Video)

July 2026

Colorectal Cancer Treatment Delay Thresholds and Metastasis Risk

July 2026

Is It Recurrent Malignancy or Benign Overgrowth? Expanding Possibilities for Dysfunctional Esophageal Stents Placed for Malignant Obstruction

July 2026

Sustained metabolic control in latent autoimmune diabetes in adults (LADA) with semaglutide therapy in a patient with multiple autoimmune comorbidities: a case report and literature review

July 2026

Construction and multi-omics validation of a five-gene ferroptosis-based model for predicting prognosis and therapy response in pancreatic ductal adenocarcinoma with immune landscape analysis

July 2026

A young pregnant woman with oesophageal cancer who responded to carboplatin plus nab-paclitaxel therapy

July 2026

Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy

July 2026

ASO Visual Abstract: Multimodal Prehabilitation and Outcomes after Gastroesophageal Cancer Surgery: A Cohort Study of Pulmonary Complications and Resilience to Major Postoperative Events

July 2026

sectionimg

dotimg

Download the app and start using it now

Download on the App Store

GET IT ON Google Play